“…Non-enzymatic approaches have been investigated by shortcutting NADH/StyB using various photo-or electrochemical methods to reduce FAD. [24][25][26][27][28][29] In particular, 1benzyl-1,4-dihydronicotinamide (BNAH) was shown to be effective and simple to use as a reductant with StyA 16,30 and other two-component flavoprotein monooxygenases such as halogenases, 31 a bacterial luciferase, 32 and an FMN-dependent type II Baeyer-Villiger monooxygenase. 33 BNAH thus circumvents the use of two enzymes (StyB, dehydrogenase) and NADH, for using oxygenase StyA in biocatalytic reactions (Figure 1B).…”